反応 #6331

ord-1f6e982b827e468188c3fc64dfc63777

反応方程式

CC(=O)NCC1OC(=O)N2c3ccccc3CC12
N-[(9,9a-Dihydro-3-oxo-1H,3H-oxazolo[3,4-a]indol-1-yl)methyl]acetamide
O=C1CCC(=O)N1Br
N-bromosuccinimide
O=C(OOC(=O)c1ccccc1)c1ccccc1
benzoylperoxide
CC(=O)NCC1OC(=O)N2c3ccc(Br)cc3CC12
title compound
CC(=O)NCC1OC(=O)N2c3ccc(Br)cc3CC12
N-[(7-bromo-9,9a-dihydro-3-oxo-1H,3H-oxazolo[3,4-a]indol-1-yl)methyl]acetamide

反応条件

詳細条件
See reaction.notes.procedure_details.

後処理

  1. 1
    その他Then a small portion is removed
  2. 2
    濃縮The mixture was then concentrated under reduced pressure

実験手順

(±) (1S,9aS/1R,9aR) N-[(9,9a-Dihydro-3-oxo-1H,3H-oxazolo[3,4-a]indol-1-yl)methyl]acetamide (X, diastereomer B, [SS,RR-trans], EXAMPLE 11, 299 mg) is dissolved in acetonitrile (10 ml). To this mixture N-bromosuccinimide (235 mg) and a catalytic amount of benzoylperoxide are added as solids to the mixture at 20°-25°. The mixture is stirred at 20°-25° in a sealed flask over night. Then a small portion is removed and examined by NMR. The mixture was then concentrated under reduced pressure to give the title compound, NMR (CDCl3, 300 MHz) 7.30, 6.49, 4.63, 4.52, 3.72, 3.29, 3.12, 2.76 and 2.06 δ.

出典

DOI: 10.6084/m9.figshare.5104873.v1特許: US05247090uspto-grants-1993_09